590 related articles for article (PubMed ID: 8106111)
1. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Ribas C; Miralles A; García-Sevilla JA
Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
[TBL] [Abstract][Full Text] [Related]
2. Chronic clorgyline induces selective down-regulation of alpha2-adrenoceptor agonist binding sites in rat brain.
Miralles A; Ribas C; Escribá PV; García-Sevilla JA
Pharmacol Toxicol; 2000 Dec; 87(6):269-75. PubMed ID: 11140825
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
4. Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
Ribas C; Miralles A; Escribá PV; García-Sevilla JA
Eur J Pharmacol; 1998 Jun; 351(1):145-54. PubMed ID: 9698216
[TBL] [Abstract][Full Text] [Related]
5. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
Barturen F; Garcia-Sevilla JA
Mol Pharmacol; 1992 Nov; 42(5):846-55. PubMed ID: 1359398
[TBL] [Abstract][Full Text] [Related]
6. Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.
Ribas C; Miralles A; Busquets X; García-Sevilla JA
Br J Pharmacol; 2001 Apr; 132(7):1467-76. PubMed ID: 11264240
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
Miralles A; Ribas C; Olmos G; García-Sevilla JA
J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
[TBL] [Abstract][Full Text] [Related]
8. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.
Olmos G; Miralles A; Barturen F; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1000-7. PubMed ID: 1545372
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous withdrawal from long-term treatment with morphine accelerates the turnover of alpha 2-adrenoceptors in the rat brain: up-regulation of receptors associated with increased receptor appearance.
Gabilondo AM; García-Sevilla JA
J Neurochem; 1995 Jun; 64(6):2590-7. PubMed ID: 7760039
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
Pinthong D; Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of alpha 2 adrenoceptors in ventrolateral medulla of spontaneously hypertensive rats.
Gulati A
Life Sci; 1991; 48(12):1199-206. PubMed ID: 1848344
[TBL] [Abstract][Full Text] [Related]
12. Use of the operational model of agonism and [3H]prazosin binding to assess altered responsiveness of alpha1-adrenoceptors in the vas deferens of spontaneously hypertensive rat.
Vivas NM; Giraldo J; Tabernero A; Vila E; Badia A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):383-91. PubMed ID: 9303577
[TBL] [Abstract][Full Text] [Related]
13. Low concentrations of angiotensin II unmask vasoconstrictory alpha 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats.
Bohmann C; Rist W; Schollmeyer P; Rump LC
Cardiovasc Res; 1995 Dec; 30(6):857-65. PubMed ID: 8746199
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment.
Callado LF; Gabilondo AM; Meana JJ
Life Sci; 1999; 64(25):2327-39. PubMed ID: 10374896
[TBL] [Abstract][Full Text] [Related]
15. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
Bhargava HN; Gulati A; Ramarao P
Biochem Pharmacol; 1991 Jun; 42(1):25-9. PubMed ID: 1648922
[TBL] [Abstract][Full Text] [Related]
17. Enhanced interaction between renovascular alpha(2)-adrenoceptors and angiotensin II receptors in genetic hypertension.
Jackson EK; Herzer WA; Kost CK; Vyas SJ
Hypertension; 2001 Sep; 38(3):353-60. PubMed ID: 11566904
[TBL] [Abstract][Full Text] [Related]
18. Repeated idazoxan increases brain imidazoline receptors in normotensive (WKY) but not in hypertensive (SHR) rats.
Olmos G; Miralles A; Barturen F; García-Sevilla JA
J Neurochem; 1991 Nov; 57(5):1811-3. PubMed ID: 1681037
[TBL] [Abstract][Full Text] [Related]
19. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
20. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
Karkanias GB; Etgen AM
Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
